Brazzein Protein Shows Potential in Reducing Blood Sugar Spikes in Study
A recent study has highlighted the potential of brazzein, a sweet protein derived from the West African oubli plant, in reducing blood sugar spikes. This research, reported by the Science Alert news outlet, was conducted by scientists at Russia’s Federal Research Centre of Nutrition, Biotechnology and Food Safety. Brazzein is notable for its intense sweetness and has been explored as a possible sugar substitute due to its natural origins and favorable properties.
The study involved a randomized trial with 101 adults diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD), a condition characterized by fat accumulation in the liver, often linked to obesity and diabetes. Participants were given a 100-gram serving of vanilla ice cream on three different occasions: one with traditional sugar, one sweetened with brazzein, and another with brazzein combined with inulin, a type of dietary fiber.
Results indicated that blood sugar spikes were significantly lower in participants who consumed the ice cream sweetened with brazzein or the combination of brazzein and inulin compared to the sugar-sweetened version. The most pronounced reductions in blood sugar levels were observed in participants with type 2 diabetes, suggesting that brazzein could offer a beneficial alternative for managing blood sugar levels.
Future Research Directions on Brazzein's Health Impact
The researchers noted the need for longer-term studies to ascertain whether regularly substituting sugar-laden desserts with those sweetened by brazzein could lead to sustained improvements in metabolic health, liver function, gut microbiome composition, or behavioral changes related to eating habits.
The health implications of sugar consumption have been a topic of extensive research and debate. In 2023, the World Health Organization issued guidelines cautioning against the use of non-sugar sweeteners for weight management, highlighting potential adverse effects from long-term use, including an increased risk of type 2 diabetes and cardiovascular diseases. As such, the exploration of alternatives like brazzein may be timely and relevant in the context of ongoing discussions about dietary health and metabolic well-being.




